Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…
LA JOLLA, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
VICTORIA, British Columbia, Feb. 08, 2023 (GLOBE NEWSWIRE) — Lucy Scientific Discovery Inc. ( “the Company”), an early-stage psychotropics contract…
Publication underscores the importance of data in underrecognized neuropathic itch disorder which lacks an approved treatmentSTAMFORD, Conn., Feb. 08, 2023…
CAMBRIDGE, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving…
Results reflect growth across all leading prescription products, demonstrating continued track record of strong overall performance Management to host conference…
STOUGHTON, Mass., Feb. 07, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced the pricing of its offering…
NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) — Cellectis S.A. (“Cellectis” or the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS),…
Preclinical evidence shows that LGR5 targeted CAR-T cells are able to kill ovarian cancer cells and to reduce ovarian cancer…
Harmony P. Garges MD MPH and Menassie Taddese MBA appointed to Medexus’s board of directors Appointments bolster Medexus board’s medical and financial expertise, particularly…